<html><body><h2>Case: 1022430</h2><h3> CDS Time: 2011-05-31</h3>
<patient name=1022430>
96.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">96</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">22</td><td width="200">1995-9-2</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">22</td><td width="200">1995-9-2</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">120</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1994-11-4</td></tr>
<tr><td width="200">Chloride</td><td width="200">96.0</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">51</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">BNP</td><td width="200">4555.0</td><td width="200">1996-10-16</td></tr>
<tr><td width="200">B 12</td><td width="200">428.0</td><td width="200">1995-9-2</td></tr>
<tr><td width="200">Weight</td><td width="200">100</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">7</td><td width="200">1995-10-15</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1994-4-24</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">147</td><td width="200">1994-4-24</td></tr>
<tr><td width="200">SGOT</td><td width="200">17</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">120</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Height</td><td width="200">59</td><td width="200">1996-10-16</td></tr>
<tr><td width="200">Potassium</td><td width="200">6</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">147</td><td width="200">1994-4-24</td></tr>
<tr><td width="200">BUN</td><td width="200">53</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">HCT</td><td width="200">29</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Sodium</td><td width="200">128</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.3</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1994-4-24</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">22.0</td><td width="200">1995-9-2</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">22</td><td width="200">1995-9-2</td></tr>
<tr><td width="200">Pulse</td><td width="200">67</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">PLT</td><td width="200">742</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">WBC</td><td width="200">4</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">eGFR</td><td width="200">40</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">SGPT</td><td width="200">20</td><td width="200">1996-12-2</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1996-10-21</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1995-12-29</td></tr>
<tr><td width="200">PVD</td><td width="200"></td><td width="200">1996-7-12</td></tr>
<tr><td width="200">Atrial_Tachycardia</td><td width="200"></td><td width="200">1996-10-17</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1996-10-21</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1996-10-21</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1995-10-21</td></tr>
</table>
<p><b>Medications:</b> aspirin(0.0) hydralazine(20.0) digoxin(0.25) furosemide(40.0) quinidine(0.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CRI</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(1.3/1996-12-2) && Sex(Female) && Creatinine(1.3/1996-12-2)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(128.0/1996-12-2)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Significant hyponatremia[Sodium(128.0/1996-12-2)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hyperuricemia[Uric_Acid(6.9/1995-10-15)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hyperkalemia[Potassium(5.7/1996-12-2)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">K>5.5 and absence ACE</td>
<td width="200"></td>
<td width="200"> Hyperkalemia[Potassium(5.7/1996-12-2) && ACE I not being used]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Sodium=<125 ever</td>
<td width="200"></td>
<td width="200"> hyponatremia in the past[Sodium(128.0/1996-12-2)]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(96.0/1970-1-1)]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(40.0/1996-12-2)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(40.0/1996-12-2)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(96.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1996-07-12</td>
<td width="200"> PVD()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1996-10-21</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1996-10-21</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1996-10-21</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr> <td width="200"></td>
<td width="200">1996-10-17</td>
<td width="200"> Atrial_Tachycardia()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1995-12-29</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1995-10-21</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">VA/JNC-VII Hypertension Guideline</h1>
<b>Patient classification:</b> <ul>
<li>VA/JNC-VII Hypertension Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(presence of diagnosis of hypertension && absence of renovascular disease && no diagnosis of pregnancy && Absense of Secondary Hypertension && absence of spinal cord injury && absence of narcolepsy && Not taking cyclosporine && Not taking spironolactone && Not taking minoxidil && absence of renovascular disease && absence of IHSS && Absence of Ascites && Not off guideline && not taking tacrolimus && absence of transplant recipient && Absence of a dialysis procedure code)</i>]
<li>Risk Group C (presence of TOD/CCD or DM): [because <i> presence of TOD/CCD or DM </i> evaluate to <b>true</b><i>(presence of TOD/CCD)</i>]
</ul>
<b>Scenario choice:</b> on one anti-hypertensive drug
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Recommendation</b>
<ul>
<li>It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: furosemide, hydralazine, digoxin
<li>The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>Primary_Recommendation</b>
<ul>
<li>Based on most recent BP in the database, BP appears to be adequately controlled; however, ALTERNATIVE DRUGS may be preferred.
</ul>
<li><b>Assumption</b>
<ul>
<li>We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>on medication: things to check</b><br>
<ul>
<li><b>assumption  check presence of BP <font color=FF0000>preferred</font></b>(rule in criterion<i> diastolic BP or systolic BP absent</i> evaluate to <b> true</b> because <i>absence of diastolic BP</i>)])
We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
<li><b>risk group C message(on med), absence of DM <font color=FF0000>preferred</font></b>(rule in criterion<i> risk group C</i> evaluate to <b> true</b> because <i>risk group C</i>)])
This patient has clinically manifest cardiovascular disease or target organ damage (Risk Group C per JNC6).  The largest benefit of anti-hypertensive therapy is seen in patients with the highest baseline risk of cardiovascular disease, therefore this patient should be considered for prompt pharmacologic therapy, even if the BP is in the high-normal range.  Appropriate lifestyle modification and attention to other reversible cardiovascular risk factors is also strongly recommended.
<li><b>adverse event warning <font color=FF0000>preferred</font></b>(rule in criterion<i> presence of current medication with adverse reaction</i> evaluate to <b> true</b> because <i>presence of current medication with adverse reaction</i>)])
<li><b>test parameterized message <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: furosemide, hydralazine, digoxin
<li><b>Disclaimer <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>one-drug-therapy-choices</b><br>
<ul>
<li><b>on one drug, consider substituting drug <font color=FF0000>preferred</font></b>(strict rule-in condition<i> BP controlled and exist non-indicated current drug and compellingly indicated drug</i> evaluate to <b> true</b> because <i>Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null) && there exists a compellingly indicated drug that is not already given && there exists a non-betablocker, non-ACE, non-clonidine , non (alpha blocker + BPH)drug to replace</i>)])

Based on most recent BP in the database, BP appears to be adequately controlled; however, ALTERNATIVE DRUGS may be preferred.
</ul>
<li><b>substitution messages</b><br>
<ul>
<li><b>NO ADE recommended drug SUB <font color=FF0000>preferred</font></b>(rule in criterion<i> there exists recommended drug and none has ADE</i> evaluate to <b> true</b> because <i>No recommended drug has adverse event && recommend delete</i>)])
No adverse reactions are listed for the antihypertensive drug(s) we are recommending.  If the patient has had an adverse reaction, please enter it in a progress note entitled "Adverse Reactions/Allergy".
</ul>
</ul>
<b>Considerations for substituting drug: </b><ul><li> Substitution: replace <ul><li>hydralazine(hydralazine)<ul><li>No comment</ul> with <li>Cardioselective Beta Blocker (atenolol)<ul><li><font color=FF0000>Compelling indications:  Heart_Failure(Cardiomegaly, Heart_Failure)  Heart Failure (second prev) BP cont(Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null) && heart failure present]) </font><li>Relative indications:  Atrial_Tachycardia(Atrial_Tachycardia)  Atrial_Fibrillation(Atrial_Fibrillation)  CKD by eGFR or ICD9 codes(CKD[eGFR(40.0/1996-12-2)]) <li>Add Beta blocker and PVD(Beta blockers may exacerbate symptoms of peripheral vascular disease (PVD). It is important to follow the effect on your individual patient.)<li>Atrial fibrillation and add NDHP orBB(Management of  arrythmia is complex and may require consultation with specialist.)<li>betablocker dyslipidemia warning message(Beta blockers may have transient adverse effects on lipids in some patients.  Consider repeating lipid profile after maximal dosage of drug has been reached if appropriate.)<li>disclaimer about procedure reports delete(Diagnoses from EKG reports are not extracted. If patient has an arrythmia that is not shown in patient summary, please update problem list.)<li>preference: preferred</ul><li>Alpha Blocker (terazosin)<ul><li>preference: neutral<li>No comment</ul><li>DHP Calcium Channel Blocker (felodipine, nifedipine SA)<ul><li>preference: neutral<li>No comment</ul><li>(non-DHP) Calcium Channel Blocker (diltiazem)<ul><li>Relative indications:  Atrial_Fibrillation(Atrial_Fibrillation)  Atrial_Tachycardia(Atrial_Tachycardia)  CKD by eGFR or ICD9 codes(CKD[eGFR(40.0/1996-12-2)]) <li>Relative contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: neutral</ul><li>Potassium Sparing Diuretic <ul><li>preference: neutral<li>No comment</ul><li>ACE Inhibitor (lisinopril)<ul><li><font color=FF0000>Compelling indications:  Heart_Failure(Cardiomegaly, Heart_Failure)  Heart Failure  (Secondary Prev) BP controlled(Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(120/null) && presence of heart failure])  CKD by eGFR or ICD9 codes(CKD[eGFR(40.0/1996-12-2)]) </font><li>Relative contraindications:  K>5.5 and absence ACE(Hyperkalemia[Potassium(5.7/1996-12-2) && ACE I not being used]) <li>ACE inhibitor and HF(Use of ACE inhibitors in patients with heart failure and ejection fraction <0.35 significantly reduces overall mortality and hospital admissions.  For patients with ejection fraction >=0.35 ACE inhibitors may be beneficial but this is not established.)<li>add ACE(2ary prevention HF), dose adjustment (When adding ACE inhibitor to this patient's therapeutic regime a dose adjustment of other anti-hypertensive drugs may be required.)<li>adding ACE inhibitor, creatinine message if K>5.5(Check the patient's creatinine when prescribing or increasing dose of  ACE Inhibitors.)<li>add ACE and Creatinine>1.3 (female)(ACE inhibitor is recommended because most recent creatinine is above 1.3mg/dl (upper normal limit for females), disregard if renal insufficiency is acute. Recheck creatinine and potassium concentration after starting ACE inhibitor therapy.)<li>Add ACE/ARB & CKD; alert creatinine rise(A stable increase of serum creatinine as much as 35% above baseline after ACEI or ARB initiation may be tolerated, as long as hyperkalemia does not occur. ACEI or ARB should be discontinued, or other potentially reversible causes of kidney failure investigated if progressive and rapid rise of serum creatinine continues. Since CKD is associated with progressive rise in creatinine over years, ACEI or ARB should not be discontinued for this situation, since these medications are renoprotective.)<li>preference: preferred</ul><li>Thiazide Diuretic (HCTZ)<ul><li>Drugs with bad interactions:  furosemide(furosemide) <li><font color=FF0000>Compelling indications:  CKD by eGFR or ICD9 codes(CKD[eGFR(40.0/1996-12-2)]) </font><li>Contraindications:  Sodium_Very_Low(<=130) most recent(Significant hyponatremia[Sodium(128.0/1996-12-2)]) <li>Relative contraindications:  Sodium-Low(hyponatremia[Sodium(128.0/1996-12-2)])  Elevated Uric Acid(Hyperuricemia[Uric_Acid(6.9/1995-10-15)])  Sodium=<125 ever(hyponatremia in the past[Sodium(128.0/1996-12-2)]) <li>preference: ruled out</ul></ul></ul></body></html>